Expanding the molecular landscape of undifferentiated sarcomas of bone with a novel EWSR1‐SSX3 gene fusion
Genes, Chromosomes and Cancer · 2024
DOI: 10.1002/gcc.23215 ↗Kurz gefasst
Fallbericht in der Zeitschrift Genes, Chromosomes and Cancer, 2024. Verfasst von Caterina Fumagalli und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. Hauptthemen laut MEDLINE: Sarcoma, Sarcoma, Ewing, Soft Tissue Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Undifferentiated sarcomas characterized by a primitive monomorphic round to spindle cell phenotype and often non‐specific immunoprofile remain difficult to subclassify outside molecular analysis. The increased application of RNA sequencing in clinical practice led to significant advances and discoveries of novel gene fusions that furthered our understanding and refined classification of otherwise undifferentiated neoplasms. In this study, we report an undifferentiated round to spindle cell sarcoma arising in the femur of a 34‐year‐old female. The round to spindle tumor cells were arranged in short fascicles, with focal rosette formation, within a hyalinized stroma. The tumor immunoprofile included diffuse reactivity for CD99, SATB2, and TLE1 and patchy positivity for Cyclin D1, Keratin AE1/AE3, synaptophysin, and chromogranin. Other markers, such as EMA, SMA, desmin, S100, ERG, and WT1, were negative. Fluorescence in situ hybridization analysis for EWSR1 gene alterations showed a break‐apart signal and targeted RNA sequencing revealed an EWSR1::SSX3 gene fusion. The patient received neoadjuvant chemotherapy followed by surgery and subsequently relapsed in less than a year with lung metastasis. Larger series are needed to determine if this fusion defines a novel subset of undifferentiated tumors or represents a genomic variant of already existing primitive round cell sarcoma categories, such as Ewing sarcoma or synovial sarcoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
- Department of Oncology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
- Department of Radiology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
- Department of Traumatology and Orthopaedics, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
- Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
ORCID-Profile: Caterina Fumagalli, Cristina R Antonescu
Förderung
- NCI NIH HHS
Zitieren
APA
Fumagalli, C., Orellana, R., Ferré, M., Gonzalez, A., Catasús, L., Vázquez, T., Sebio, A., López-Pousa, A., Llauger, J., Peiró, A., & Antonescu, C. R. (2024). Expanding the molecular landscape of undifferentiated sarcomas of bone with a novel EWSR1‐SSX3 gene fusion. Genes, Chromosomes and Cancer. https://doi.org/10.1002/gcc.23215
Vancouver
Fumagalli C, Orellana R, Ferré M, Gonzalez A, Catasús L, Vázquez T, et al. Expanding the molecular landscape of undifferentiated sarcomas of bone with a novel EWSR1‐SSX3 gene fusion. Genes, Chromosomes and Cancer. 2024. doi:10.1002/gcc.23215
BibTeX
@article{Fumagalli2024,
author = {Fumagalli, Caterina and Orellana, Ruth and Ferré, Malena and Gonzalez, Allan and Catasús, Lluis and Vázquez, Tania and Sebio, Ana and López-Pousa, Antonio and Llauger, Jaume and Peiró, Ana and Antonescu, Cristina R},
title = {Expanding the molecular landscape of undifferentiated sarcomas of bone with a novel EWSR1‐SSX3 gene fusion},
journal = {Genes, Chromosomes and Cancer},
year = {2024},
doi = {10.1002/gcc.23215}
}
EUVIMED